113 results
Page 2 of 6
8-K
EX-99.1
eidczh 05
10 Jul 23
Regulation FD Disclosure
4:06pm
8-K
EX-99.1
p45sebxt7j6 vpfz
9 May 23
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
p1yskg
3 May 23
Soleno Therapeutics Completes Enrollment in Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
5:26pm
8-K
j7whjzd1 u1hpk
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-99.1
mnw r9vvi3n
9 Nov 22
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:11pm
8-K
EX-99.1
fs7zyb6dkhotm55hvaq
10 Aug 22
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:06pm
8-K/A
5j17kib3h
25 Jul 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
EX-99.1
0yarodzal10h2wmokk
10 May 22
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:01pm
424B5
4r59nulwp cm4rzkg
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
f73sn
28 Mar 22
Prospectus supplement for primary offering
4:53pm